RefleXion

About RefleXion

RefleXion is a Other / Uncategorized company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• STAT News · 2026-04-01
  Reflexion partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Imaging Wire · 2026-03-06
  Reflexion files IND for next-generation PSMA-targeted agent
  Coverage notes the company's growing footprint in the radioligand therapy space.
• PR Newswire · 2026-10-15
  Reflexion publishes dosimetry data at SNMMI 2026
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Nuclear Medicine Today · 2026-05-08
  Reflexion closes Series C round to scale radiopharma manufacturing
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Endpoints News · 2026-08-01
  Reflexion signs supply agreement to support late-stage trials
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.